Companies / Pardes Biosciences, Inc.
Pardes Biosciences, Inc.
FSIIPRDSCIK 1822711
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 23, 2021 | Tananbaum James B. Executive | Grant Grant or award | Common Stock | $10.00M | +1.0M | 1,000,000 | low |
| Feb 19, 2021 | FS Development Holdings II, LLC 10% owner | Buy Open-market buy | Class A Common Stock | $6.03M | +603K | 602,500 | high |
| Dec 22, 2021 | Tananbaum James B. Executive | Buy Open-market buy | Common Stock | $3.25M | +325K | 325,000 | high |
| Apr 5, 2023 | Foresite Capital Opportunity Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $1.16M | +774K +9.68% | 8,773,134 | high |
| Apr 5, 2023 | Foresite Capital Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $1.16M | +774K +6.04% | 13,583,762 | high |
| Dec 1, 2022 | Foresite Capital Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $541.8K | +637K +5.24% | 12,809,810 | high |
| Dec 1, 2022 | Wiggans Thomas G CEO | Buy Open-market buy | Common Stock | $26.0K | +25K | 25,000 | low |
| Dec 8, 2022 | Brusky Sean P. Executive | Buy Open-market buy | Common Stock | $25.0K | +21K | 21,000 | low |